Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori
Summary
The goal of this Randomized controlled trial is to assessment Efficacy of Vonoprazan versus Proton Pump Inhibitors in Combination with Antibiotics as a triple Therapy for Eradication of Clarithromycin Resistant Strain of Helicobacter Pylori (H. pylori). This randomized controlled study was performed on 2 groups of Egyptian patients diagnosed with dyspepsia; group (1) included 160 patients received Vonoprazan 20 mg oral once daily + Levofloxacin 500 mg oral once daily + Amoxicillin 1 gm oral twice daily for 14 days and group (2) included 160 patients received Pantoprazole 40 mg oral twice daily + Levofloxacin 500 mg oral once daily + Amoxicillin 1 gm oral twice daily for 14 days. All patients of the two groups were followed up for persistence of infection 8 weeks after the end of treatment by testing fecal H. pylori antigen (Ag).
Timeline
- Start
- 2023-10-12
- Primary completion
- 2024-04-04
- Completion
- 2024-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pantoprazole | Other / unclassified | 40 mg | Oral |
| Comparator | Vonoprazan | Other / unclassified | 20 mg | Oral |
| Comparator | Amoxicillin | Other / unclassified | 1 g | Oral |
| Comparator | Levofloxacin | Small molecule | 500 mg | Oral |